Australas J Dermatol. 2022 Feb 23. doi: 10.1111/ajd.13809. Online ahead of print.

BIDIRECTIONAL ASSOCIATION BETWEEN ALOPECIA AREATA AND IRRITABLE BOWEL SYNDROME: A NATIONWIDE POPULATION-BASED COHORT STUDY

Ying-Xiu Dai, Ying-Hsuan Tai, Yun-Ting Chang, Tzeng-Ji Chen, Mu-Hong Chen

Abstract

Background: Alopecia areata (AA) and irritable bowel syndrome (IBS) are two distinct diseases that share a similar pathophysiology; however, the relationship between these two diseases is unknown. This study aimed to investigate the bidirectional relationship between AA and IBS.

Methods: Participants were recruited from the National Health Insurance Research Database in Taiwan. We included 5446 patients with AA and 21 784 matched controls to assess the risk of IBS, and 56 429 patients with IBS and 225 716 matched controls to assess the risk of AA. The Cox proportional-hazards regression model was used to calculate the adjusted hazard ratio (aHR).

Results: After adjustment for potential confounders, patients with AA had an aHR of 5.20 [95% confidence interval (CI) 3.97-6.82] for IBS in comparison with the controls. Furthermore, compared with the controls, IBS patients had an aHR of 5.38 (95% CI 3.95-7.34) for AA.

Conclusion: AA is bidirectionally associated with IBS. Further investigation is needed to elucidate the shared pathogenesis underlying these two diseases.

Keywords: Taiwan’s National Health Insurance Research Database; alopecia areata; cohort study; epidemiology; irritable bowel syndrome.

©2022 Australasian College of Dermatologists.

BIBLIOGRAFIA
1. Safavi KH, Muller SA, Suman VJ et al. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin. Proc. 1995; 70: 628-33.
2. Rajabi F, Drake LA, Senna MM et al. Alopecia areata: a review of disease pathogenesis. Br. J. Dermatol. 2018; 179: 1033-48.
3. Dai YX, Tai YH, Chang YT et al. Association between major depressive disorder and subsequent autoimmune skin diseases: a nationwide population-based cohort study. J. Affect. Disord. 2020; 274: 334-8.
4. Dai YX, Yeh CP, Chen CC. Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata. Dermatol Sin. 2020; 38: 3-8.
5. Gwee KA, Bak YT, Ghoshal UC et al. Asian consensus on irritable bowel syndrome. J. Gastroenterol. Hepatol. 2010; 25: 1189-205.

Leggi l’articolo originale: CLICCA QUI!